Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [(153)Sm]Sm-DOTA-TATE

Mostrar otras versiones (1)

Samarium-153 is a promising theranostic radionuclide, but low molar activities (A(m)) resulting from its current production route render it unsuitable for targeted radionuclide therapy (TRNT). Recent efforts combining neutron activation of (152)Sm in the SCK CEN BR2 reactor with mass separation at C...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeulen, Koen, Van de Voorde, Michiel, Segers, Charlotte, Coolkens, Amelie, Rodriguez Pérez, Sunay, Daems, Noami, Duchemin, Charlotte, Crabbé, Melissa, Opsomer, Tomas, Saldarriaga Vargas, Clarita, Heinke, Reinhard, Lambert, Laura, Bernerd, Cyril, Burgoyne, Andrew R., Cocolios, Thomas Elias, Stora, Thierry, Ooms, Maarten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785812/
https://www.ncbi.nlm.nih.gov/pubmed/36559060
http://dx.doi.org/10.3390/pharmaceutics14122566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785812/
https://www.ncbi.nlm.nih.gov/pubmed/36559060
http://dx.doi.org/10.3390/pharmaceutics14122566

Ejemplares similares